Opioids Market Outlook Highlights The Next Major Growth Opportunities
Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Opioids Market Size Forecast: How Large Could The Market Become By 2030?
The opioids market has seen consistent expansion in recent times. Its value is projected to reach $23.98 billion in 2025 and then climb to $24.63 billion in 2026, representing a compound annual growth rate (CAGR) of 2.7%. This historical growth was driven by several factors: the frequent occurrence of post-surgical pain, a higher incidence of cancer, extensive opioid prescribing patterns, a shortage of alternative treatments for pain, and a significant reliance on opioids within hospital environments.
The opioids market is projected to experience consistent expansion in the coming years, reaching a value of $28.59 billion by 2030, with a compound annual growth rate (CAGR) of 3.8%. This anticipated growth during the forecast period is driven by factors such as an increasing number of individuals living with chronic pain, the creation of opioid formulations with improved safety profiles, the widening of palliative care services, more defined regulatory frameworks concerning controlled substances, and a heightened need for effective pain relief solutions among older populations. Key developments shaping the industry in the forecast period involve the advancement of precision-based opioid therapies, the incorporation of digital monitoring systems for prescriptions, a transition toward abuse-deterrent product designs, a growing emphasis on long-acting and extended-release opioid options, and a rising utilization of opioids for managing pain associated with cancer.
Download A Free Sample Report For Comprehensive Market Insights:
Opioids Market Development Factors: Which Trends Are Supporting Demand?
The rising incidence of chronic diseases is anticipated to drive expansion in the opioids market moving forward. Chronic diseases, often referred to as non-communicable diseases (NCDs), are long-term health conditions that typically advance slowly and endure over an extended timeframe. These conditions can last for years or even a lifetime and generally do not resolve spontaneously. The growing frequency of chronic diseases significantly influences the opioids market. As more individuals develop chronic illnesses and suffer from persistent pain, the demand for opioids escalates. The application of opioids in managing chronic diseases represents a complex and evolving field of medicine, offering effective pain relief. For example, in June 2024, data from the National Health Service, a UK government agency, revealed that 3,615,330 people registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes (a condition characterized by elevated blood sugar levels not yet reaching diabetes thresholds) in 2023, reflecting an 18% rise from 3,065,825 cases in 2022. Consequently, the increasing prevalence of chronic diseases is fueling growth in the opioids market.
Opioids Market Segment Breakdown: Which Categories Generate The Most Revenue?
The opioids market covered in this report is segmented –
1) By Product Type: Methadone, Codeine, Fentanyl, Oxycodone, Morphine, Hydrocodone, Other Product Types
2) By Receptor Binding: Strong Agonist, Mild To Moderate Agonist
3) By Basis Of Indication: Inflammatory Condition, Musculoskeletal Pain, Neuropathic Pain, Cancer Pain
4) By Distribution Channel: Hospital, Retail Pharmacies, Online Pharmacies
5) By Application: Pain Management, Cough Treatment, Diarrhea Treatment
Subsegments:
1) By Methadone: Methadone Tablets, Methadone Oral Solution
2) By Codeine: Codeine Phosphate Tablets, Codeine Liquid Formulations
3) By Fentanyl: Fentanyl Patch, Fentanyl Injection, Fentanyl Sublingual Tablets
4) By Oxycodone: Oxycodone Tablets, Oxycodone Extended-Release Formulations
5) By Morphine: Morphine Sulfate Tablets, Morphine Injection, Morphine Extended-Release Capsules
6) By Hydrocodone: Hydrocodone/Acetaminophen Tablets, Hydrocodone Liquid Formulations
7) By Other Product Types: Buprenorphine, Tramadol, Other Combination Products
Opioids Market Transformation Trends: Which Innovations Are Driving Change?
Leading players within the opioid sector are concentrating on developing cutting-edge pharmaceutical solutions to strengthen their market standing. The creation of novel drugs has the potential to address illnesses while advancing medical knowledge and healthcare outcomes. As an example, in May 2023, Braeburn Pharmaceuticals Inc., a company based in the United States specializing in treatments for opioid addiction, announced that the US Food and Drug Administration had approved Brixadi (buprenorphine) as an extended-release injectable for subcutaneous administration (under the skin) to manage moderate to severe opioid use disorder (OUD). This product is the first and only weekly and monthly subcutaneous injectable for moderate to severe OUD, as well as the first buprenorphine injectable that employs FluidCrystal Injection Depot Technology. Patients currently using oral buprenorphine-based medications can be switched to corresponding doses when the prescribing guidelines are adhered to.
Opioids Market Key Players And Strategic Industry Positioning
Major companies operating in the opioids market are Pfizer Inc., Johnson & Johnson Inc., AbbVie Inc., Sanofi S.A, AstraZeneca Plc, Viatris Inc., Teva Pharmaceutical Industries Limited, Sandoz Inc., Sun Pharmaceutical Industries Limited, Aurobindo Pharma Limited, Purdue Pharma L.P., Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals plc, Endo Pharmaceuticals Inc., Amneal Pharmaceuticals Inc., Mallinckrodt Pharmaceuticals plc, Alkermes plc, Lannett Co Inc., Par Pharmaceutical Inc., Mayne Pharma Group Ltd., Cephalon LLC, Insys Therapeutics Inc., Janssen Pharmaceuticals Inc., Rhodes Pharmaceuticals L.P, KVK Tech Inc.
Access The Complete Opioids Market Report:
Opioids Market Global Footprint: Which Region Holds Market Leadership?
North America was the largest region in the opioids market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the opioids market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
